Comparaisons Financières IRIDEX Corporation
Actions
IRIX
US4626841013
Equipement et technologie médicale avancés
|
Marché Fermé -
Autres places de cotation
|
Varia. 5j. | Varia. 1 janv. | ||
| 1,120 USD | -0,88% |
|
-2,61% | -1,75% |
| 19/05 | Transcript : IRIDEX Corporation, Q1 2026 Earnings Call, May 19, 2026 | |
| 19/05 | IRIDEX Corporation publie ses résultats pour le premier trimestre clos le 4 avril 2026 | CI |
Principaux concurrents
Ajouter à une liste 0 sélectionné | Chiffre d'affaires (N-1) | Marge nette (N-1) | Marge EBIT (N-1) | ROE (N-1) | ROA (N-1) | Leverage (N-1) | |
|---|---|---|---|---|---|---|---|
| 52,68 M | -8,42% | -4,88% | - | - | - | ||
| 44,56 Md | 15,05% | 22,69% | 16,79% | 8,32% | 2.65x | ||
| 10,06 Md | 28,38% | 37,36% | 16,57% | 14,57% | -0.77x | ||
| 24,57 Md | 14,71% | 28,24% | 10,94% | 4,49% | 1.8x | ||
| 20,07 Md | 14,44% | 27,96% | 19,89% | 11,01% | 1.59x | ||
| 6,07 Md | 17,69% | 27,09% | 14,73% | 11,2% | -2.02x | ||
| 27,43 Md | 9,17% | 16,49% | 14,77% | 5,92% | 2.84x | ||
| 6,95 Md | 18,75% | 25,66% | 25,19% | 12,96% | 0.8x | ||
| 3,17 Md | 20,3% | 30,47% | 29,28% | 13,34% | 0.62x | ||
| 20,62 Md | 10,1% | 15,3% | 22,14% | 5,95% | 1.47x | ||
| 5,15 Md | 27,22% | 34,26% | 25,97% | 18,7% | -0.29x | ||
| 4,76 Md | 24,44% | 29,43% | 22% | 14,04% | -1.53x | ||
| 20,94 Md | 5,02% | 12,31% | 13,12% | 5,39% | 1.74x | ||
| 4,34 Md | 19,57% | 23,12% | 29,67% | 11,68% | 0.29x | ||
| 6,66 Md | 11,82% | 16,29% | 15,6% | 10,72% | -0.1x | ||
| 2,86 Md | 8,45% | 27,08% | 7,91% | 4,8% | 2.73x | ||
| 3,44 Md | -0,65% | 12,6% | 13,02% | 4,62% | 2.95x | ||
| 1,85 Md | 5,55% | 11,94% | 13,41% | 6,96% | - | ||
| 397 M | -7,99% | -9,51% | -2,86% | -2,31% | -19.22x | ||
| Moyenne | 11,26 Md | 12,29% | 20,21% | 17,12% | 9,02% | -0,26x | |
| Moyenne pondérée par Capi. | 20,41 Md | 17,37% | 26,59% | 17,43% | 9,82% | 0,97x |
- Bourse
- Actions
- Action IRIX
- Secteur IRIDEX Corporation
- Comparaisons Financières
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national
















